Bioscience

Capstone Therapeutics announces compliance with Nasdaq listing rules

March 5, 2010

By Flinn Foundation

[Source: CNN Money] – Capstone Therapeutics today announced it received a letter on March 4, 2010 from The Nasdaq Stock Market notifying the Company that it is now in compliance with the Nasdaq Listing Rules for continued listing on The Nasdaq Capital Market.

For more information: Capstone Therapeutics Announces Compliance With Nasdaq Listing Rules for Continued Listing on The Nasdaq Capital Market